Endocrine Society Conference Courier Report

CME Certificate Registration and Pretest
To enable us to measure the quantitative and qualitative effectiveness of this continuing medical education program, we ask that you take a few minutes to complete the preprogram questionnaire below prior to this activity and the CME evaluation and postprogram questionnaire upon activity completion.

Your certificate for continuing education credit (if applicable) will be issued from the following information and upon completion of the evaluation after review of the activity.

Endocrinology   Family medicine   Internal medicine   Primary Care   Urology
Other (please specify)
Clinic                      Home care             Hospital-based           Long-term care
Private practice      University-based   Other (please specify)
Business  Personal
(Used for record-keeping purposes only)
Because you have attended or shown interest in our programs, we may send you information on this and similar programs utilizing the e-mail address provided. You may unsubscribe at any time by clicking on the “unsubscribe” link on any e-mails received from us.

Please do not send me information via e-mail.

We value the confidentiality of the information you choose to share with us and are committed to its protection. All personal information you provide is stored in a secure location and will never be sold or distributed to any third party.



PRETEST

1. Patients receiving testosterone therapy should be monitored for safety concerns and ______.
 To evaluate the efficacy of the testosterone therapy
 To ensure that the goal of attaining mid-normal serum testosterone levels is attained
 To prompt evaluation of continuing testosterone therapy if there is a lack of clinical response
 All of the above

2. According to a study by Ng Tang Fui and colleagues, men with type 1 diabetes had ______ endogenous total testosterone levels compared to those with type 2 diabetes.
 Higher
 Lower
 Equivalent
 Incomparable

3. Shores et al's retrospective cohort study using US Department of Veterans Affairs electronic medical records for 1031 men aged 40 years or older with low total testosterone levels (<250 ng/dL) suggested that testosterone therapy is associated with decreased mortality, particularly in men ______.
 Aged 40 to 65 years
 With coronary heart disease
 Aged 40 to 65 years with type 2 diabetes
 None of the above



   




© 2011 CogniMed Inc. All rights reserved.            TU13127/ACHS 4840             August 2011